PBPIA
KRTX
Pivotal bioVenture Partners Investment Advisor’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-797,008
| Closed | -$252M | – | 12 |
|
|
2023
Q4 | $252M | Hold |
797,008
| – | – | 63.99% | 1 |
|
|
2023
Q3 | $135M | Buy |
797,008
+15,000
| +2% | +$2.54M | 53.75% | 1 |
|
|
2023
Q2 | $170M | Hold |
782,008
| – | – | 55.9% | 1 |
|
|
2023
Q1 | $142M | Buy |
782,008
+16,113
| +2% | +$2.93M | 58.49% | 1 |
|
|
2022
Q4 | $150M | Hold |
765,895
| – | – | 65.45% | 1 |
|
|
2022
Q3 | $172M | Sell |
765,895
-115,563
| -13% | -$26M | 62.95% | 1 |
|
|
2022
Q2 | $112M | Buy |
881,458
+28,750
| +3% | +$3.64M | 56.18% | 1 |
|
|
2022
Q1 | $108M | Hold |
852,708
| – | – | 51.15% | 1 |
|
|
2021
Q4 | $112M | Hold |
852,708
| – | – | 46.71% | 1 |
|
|
2021
Q3 | $104M | Hold |
852,708
| – | – | 36.87% | 1 |
|
|
2021
Q2 | $97.2M | Sell |
852,708
-56,000
| -6% | -$6.38M | 38.31% | 1 |
|
|
2021
Q1 | $109M | Sell |
908,708
-174,636
| -16% | -$21M | 35.05% | 1 |
|
|
2020
Q4 | $110M | Buy |
+1,083,344
| New | +$110M | 36.29% | 1 |
|